Why are CSL shares falling today?

CSL shareholders may have mixed feelings today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The CSL Ltd (ASX: CSL) share price is down 2% in early trading as the ASX healthcare share feels the effects of the ASX stock market sell-off. CSL shares also went ex-dividend today.

On Friday in the US market, there was a sizeable decline in a number of stocks. Nvidia fell 5.5%, Eli Lilly dropped 2.3%, Microsoft declined 0.7%, Tesla fell 1.8% and so on. The S&P/ASX 200 Index (ASX: XJO) is currently down by 1.3%.

Cropped shot of an attractive young female scientist working on her computer in the laboratory.

Image source: Getty Images

Ex-dividend day

One of the factors that may be impacting CSL shares today is that it went ex-dividend.

An ex-dividend date tells the market when new investors buying shares will miss out on the upcoming dividend. There has to be a cut-off point for deciding who will and who won't receive the dividend.

Anyone who buys today is missing out on the interim dividend payment. Investors who bought CSL shares last week are eligible to receive the dividend, assuming they're still shareholders on the record date (tomorrow).

How much is being paid?

CSL is going to pay a dividend of US$1.19 to shareholders, which at the time of the FY24 first-half result translated into approximately A$1.81 per share (an increase of 12%).

At the current exchange rates, the upcoming payment equates to A$1.80 per share.

CSL is expecting to release information about exchange rates for Australian and New Zealand dollar payments on 14 March 2024.

The ASX healthcare share is planning to pay this dividend on 3 April 2024, which is only a few weeks away.

CSL was able to deliver a bigger dividend after growing net profit after tax (NPAT) by 17% to US$1.9 billion in its FY24 first-half result. It also reported underlying earnings per share (EPS) growth of 11% to US$4.18.

Profit expectations

The company is expecting to report underlying NPATA of between US$2.9 billion to US$3 billion, which would be growth of between 13% to 17%.

Management thinks the business is in a strong position to deliver annualised double-digit earnings growth over the medium term.

On Commsec, the estimates imply the CSL share price is currently valued at 30 times FY24's estimated earnings. It could pay an annual dividend of A$4, according to Commsec, which puts the forecast forward dividend yield at 1.4%.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Microsoft, Nvidia, and Tesla. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool Australia has recommended CSL and Nvidia. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A woman looks nonplussed as she holds up a handful of Australian $50 notes.
Healthcare Shares

Is this one of the best ASX 200 stocks money can buy?

High margins, strong growth, and global expansion have helped this ASX company stand out to me.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Healthcare Shares

Why is this ASX 200 share charging 7% higher today?

This stock is making its shareholders smile on Tuesday. Let's find out why.

Read more »

A patient in a hospital bed is reassured by a doctor.
Healthcare Shares

Here's why Ramsay Health Care shares have been demolishing the stock market

Investors are warming to the healthcare stock’s earnings recovery.

Read more »

Three businesspeople leap high with the CBD in the background.
Healthcare Shares

Telix shares jump 14% on big news

Let's see what this radiopharmaceuticals company has announced this morning.

Read more »

Rede arrow on a stock market chart going down.
52-Week Lows

Why the CSL share price just hit a 9-year low

CSL shares slump to levels last seen in December 2017.

Read more »

A man with a comical look on his face holds his hands in a 'time out' gesture.
Healthcare Shares

Why the Immutep share price is halted today

Immutep shares are frozen as investors await a major trial update.

Read more »

Female pharmacist smiles with a digital tablet.
Healthcare Shares

This small cap ASX biotech could double in under a year, Bell Potter says

The latest profit was just what the doctor ordered.

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Healthcare Shares

Why CSL shares are rebounding today after falling to an 8-year low

CSL shares rebound after hitting an 8-year low as brokers see a potential upside.

Read more »